PHILADELPHIA, Aug. 22, 2025 /PRNewswire/ -- abrdn Japan Equity Fund, Inc. (NYSE: JEQ) today announces additional details relating to the Fund's tender offer and anticipated closing details relating to its upcoming reorganization with abrdn Global Infrastructure Income Fund (NYSE: ASGI).Tender Offer Timeline Tender Offer Expiration Date: September 2, 2025The tender offer will expire at 5:00 PM ET, unless extended by the company. Tender Offer Valuation Date: September 3, 2025The tender offer will price per sh ...

Core Viewpoint - Rocket Companies, Inc. is initiating tender offers to acquire outstanding senior notes from Nationstar Mortgage Holdings Inc. as part of its acquisition of Mr. Cooper Group Inc. [1][2] Tender Offers - The company is offering to purchase 5.125% Senior Notes due 2030 and 5.750% Senior Notes due 2031, with aggregate principal amounts of US$650 million and US$600 million respectively [3][4] - The tender offer consideration for both notes is set at $962.50 per $1,000 principal amount, with an early tender payment of $50, bringing the total tender offer consideration to $1,012.50 for early tenders [3][4] Consent Solicitations - The company is soliciting consents to amend the indentures governing the notes, which includes eliminating the "Change of Control" offer requirement and most restrictive covenants [2][9] - A majority of the aggregate principal amount of the notes must provide consent for the proposed amendments to be adopted [9] Timeline and Conditions - The tender offers and consent solicitations will expire on September 2, 2025, with an early tender deadline of August 15, 2025 [7][11] - The consummation of the tender offers is contingent upon receiving the requisite consents and the successful completion of the acquisition of Mr. Cooper [10]

Group 1 - Black Pearl Equities announced a tender offer to purchase up to 49.9% of the outstanding common shares of Regional Health Properties at a price of $4.25 per share in cash, expiring on August 31, 2025 [1] - The tender offer provides liquidity for shareholders and an alternative to holding their investment, allowing them to tender shares at a premium to recent market prices [2] - The offer is contingent upon obtaining valid tenders for a minimum of 45% of the outstanding shares and other specific conditions, including no material adverse changes to the company's financial or operational condition [3]

Core Viewpoint - Transom Capital Group has successfully completed a tender offer to acquire SigmaTron International, with 71.9% of shares validly tendered at a price of $3.02 per share, and the acquisition is expected to be finalized on July 28, 2025 [1][2][3] Group 1: Acquisition Details - The tender offer for SigmaTron shares expired on July 24, 2025, with a purchase price of $3.02 per share [1] - A total of 4,401,189 shares were validly tendered, representing 71.9% of the outstanding shares [2] - All conditions for the tender offer have been satisfied, and Transom will accept and pay for the validly tendered shares [2] Group 2: Company Background - Transom Capital Group is a private equity firm founded in 2008, specializing in operationally-focused investments in the middle market [5] - The firm has a strong track record in various economic cycles, focusing on corporate carve-outs and undervalued public companies [5][6] - SigmaTron operates as an independent provider of electronic manufacturing services, with facilities in the U.S., Mexico, China, and Vietnam [7] Group 3: Advisory Roles - Kirkland & Ellis LLP is serving as the legal advisor for Transom [4] - Lincoln International is the exclusive financial advisor for SigmaTron, with additional legal support from Greenberg Traurig, LLP and Howard & Howard Attorneys PLLC [4]

Basel, June 25, 2025 – Novartis today announced that its previously announced tender offer (the “Offer”) by Redwood Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of Novartis (“Purchaser”), to acquire all of the outstanding shares of common stock, par value $0.001 per share (the “Shares”), of Regulus Therapeutics Inc. (“Regulus”), in exchange for (i) $7.00 in cash per share, subject to any applicable withholding and without interest thereon, plus (ii) one contingent value ri ...

Core Viewpoint - Crown Electrokinetics Corp. has entered into a definitive Merger Agreement with Crown EK Acquisition LLC, which will lead to Crown becoming a wholly owned subsidiary of Parent, controlled by Douglas Croxall, the Company's Chairman and CEO [1][2][3]. Group 1: Merger Agreement Details - The Merger Agreement stipulates that Purchaser will initiate a tender offer to acquire all outstanding shares of Crown's common stock at a cash price of $3.15 per share [2]. - The transaction has received unanimous approval from a special committee of independent directors, who determined it to be fair to Crown's unaffiliated public stockholders [3]. - The tender offer is expected to commence within 15 business days and will remain open for 20 business days, unless extended [4]. Group 2: Transaction Structure and Timeline - The transaction is not subject to a financing condition and is anticipated to close promptly after the successful completion of the tender offer [4]. - Additional information regarding the transaction will be filed with the SEC and made available on Crown's investor relations website [5]. Group 3: Company Overview - Crown is recognized as a leading provider of innovative technology infrastructure solutions, operating across multiple sectors including Smart Windows and Construction [6].

Group 1 - The Company intends to consider the delisting of all outstanding shares from trading on the regulated market AB Nasdaq Vilnius at an extraordinary general meeting scheduled for 30 June 2025 [1] - Shareholders wishing to vote "for" the delisting decision are encouraged to submit their draft resolutions by 5 June 2025 [1] - A letter from shareholder AB "HISK" has been received regarding the provision of draft decisions for the upcoming meeting [1] Group 2 - The draft resolution proposes to initiate the delisting of all outstanding shares from trading on the regulated market AB Nasdaq Vilnius [2] - Article 33(7) of the Law of the Republic of Lithuania on Securities requires shareholders voting "for" the delisting to submit a tender offer, but the proposal allows AB "HISK" to submit the tender offer while other shareholders retain the right to sell their shares during the tender offer [3] - The decisions regarding delisting and the related tender offer are valid only if the tender offer price does not exceed the established price [3] Group 3 - The tender offer price for delisting will be set at EUR 0.735, which includes a 33% premium over the fair price of EUR 0.553 as per the relevant legal provisions [4] - The draft resolution authorizes the General Manager of the Company to take necessary actions and submit documents for the delisting process after the tender offer is implemented [5][6]

Core Viewpoint - The Dow Chemical Company ("TDCC") has announced a tender offer to purchase certain debt securities for an aggregate consideration of up to $1.0 billion, which includes securities from its subsidiaries Rohm and Haas and Union Carbide Corporation [1][10]. Group 1: Tender Offer Details - The tender offer is part of TDCC's strategy to manage its debt and is detailed in the Offer to Purchase dated February 25, 2025 [1][10]. - The early participation date for the tender offer was set for March 10, 2025, and the expected early settlement date is March 13, 2025 [5][6]. - Holders of validly tendered securities will receive total consideration in cash, which includes an early participation amount of $30 per series of securities [4][6]. Group 2: Securities Information - The tender offer includes various series of securities, with specific amounts and terms outlined, such as the 0.500% Notes Due 2027 and the 7.850% Debentures Due 2029, which have been accepted for purchase [3][9]. - The total consideration for each $1,000 or €1,000 principal amount of securities validly tendered includes accrued interest from the last payment date to the early settlement date [7][8]. - Due to the tender cap, not all tendered securities will be accepted; only specific amounts of certain securities will be purchased on a prorated basis [9]. Group 3: Financial Management - TDCC has retained Citigroup Global Markets Inc. and HSBC Securities (USA) Inc. as joint lead dealer managers for the tender offer, indicating a structured approach to managing the transaction [11]. - The company aims to optimize its capital structure through this tender offer, reflecting a proactive stance in financial management [1][10]. Group 4: Company Background - Dow Inc. operates as a leading materials science company with a focus on high-growth markets, achieving approximately $43 billion in sales in 2024 [14]. - Rohm and Haas and Union Carbide Corporation are wholly owned subsidiaries of TDCC, contributing to its diversified portfolio in chemicals and polymers [15].